Marché POCT lipidique en Amérique du Nord, par type (instruments, consommables et kits), application (hyperlipidémie, hypertriglycéridémie, hyperlipoprotéinémie, hypercholestérolémie familiale, maladie de Tangier, autres), mode (tests sur ordonnance, tests en vente libre), marque (Roche Reflotron, Roche Cobas B 101, Alere Cholestech LDX, Alere Afinion, Samsung Labgeo, PTS Cardiochek, autres), plateforme (tests à flux latéral (tests d'immunochromatographie), diagnostics moléculaires, immuno-essais, bandelettes réactives, microfluidique), utilisateur final (hôpitaux, centres de diagnostic professionnels, soins à domicile, laboratoires de recherche, autres utilisateurs finaux), canal de distribution (appel d'offres direct, ventes au détail), pays (États-Unis, Canada et Mexique) Tendances et prévisions de l'industrie jusqu'en 2028
Analyse et perspectives du marché : marché POCT lipidique en Amérique du Nord
Le marché POCT lipidique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 4,9% au cours de la période de prévision de 2021 à 2028 et devrait atteindre 457,20 millions USD d'ici 2028. L'augmentation du nombre d'infections chroniques a conduit les gens à opter pour des kits et des produits au point de service pour les tests et cela stimulera donc la croissance du marché POCT lipidique.
Le POCT est un test qui peut être effectué à proximité du patient et au cours duquel une décision médicale peut être prise immédiatement, y compris les résultats et le suivi . Le POCT lipidique est également appelé test lipidique sur patient et permet aux médecins de mesurer avec précision des résultats de diagnostic de qualité laboratoire en temps réel en moins de quelques minutes au lieu de plusieurs heures.
Les nouvelles avancées biotechnologiques ont créé d'immenses facteurs de stimulation et ont stimulé la croissance du marché POCT lipidique. Le coût élevé des produits peut entraver la croissance du marché POCT lipidique. L'augmentation des dépenses de santé devrait constituer une opportunité pour la croissance du marché POCT lipidique. Le manque d'alignement avec les résultats des tests obtenus en laboratoire crée un immense défi pour le marché POCT lipidique.
Le rapport sur le marché POCT lipidique fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché POCT lipidique, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des POCT lipidiques
The lipid POCT market is segmented into seven notable segments which are based on the type, application, mode, brand, platform, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the lipid POCT market is segmented into instruments, consumables and kits. In 2021, the instruments segment in the lipid POCT market is expected to grow due to changing lifestyles and increasing chronic diseases and a lack of awareness of over-the-counter POCT devices.
- On the basis of application, the lipid POCT market is segmented into hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, tangier disease, familial hypercholesterolemia and others. In 2021, the hyperlipidemia segment in the lipid POCT market is expected to dominate because of the rising geriatric population and unhealthy lifestyle.
- On the basis of mode, the lipid POCT market is segmented into OTC-based testing and prescription-based testing. In 2021, the prescription-based test segment in the lipid POCT market is expected to dominate because of high preference of point of care lipid testing been recommended for lipid profiling in hospitals and skilled laboratory professionals.
- On the basis of brand, the lipid POCT market is segmented into roche reflotron, roche cobas B 101, alere cholestech LDX, alere afinion, samsung labgeo, PTS cardiochek and others. In 2021, the roche reflectron segment is expected to dominate in lipid POCT market due to their advanced technology over point of care devices.
- On the basis of platform, the lipid POCT market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2021, the lateral flow assays (immunochromatography tests) segment in the lipid POCT market is expected to grow due to advanced technologies and inventions.
- On the basis of end user, the lipid POCT market is segmented into hospitals, professional diagnostic centers, home care, research laboratories and other end users. In 2021, the hospitals segment in the lipid POCT market is expected to grow due to growing patient emphasis on diagnosis operations.
- On the basis of distribution channel, the lipid POCT market is segmented into direct tender and retail sales. In 2021, direct tender segment in the lipid POCT market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.
Lipid POCT Market Country Level Analysis
The lipid POCT market is analysed and market size information is provided by the country, type, application, mode, brand, platform, end user and distribution channel as referenced above.
The countries covered in North America lipid POCT market are U.S., Canada and Mexico.
The U.S. is dominating the market due to increasing prevalence of chronic diseases and rising technological advancements.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufacturers is Creating New Opportunities for Players in the Lipid POCT Market
The lipid POCT market also provides you with detailed market analysis for every country growth in aesthetic industry with lipid POCT market sales, impact of advancement in the lipid POCT market and changes in regulatory scenarios with their support for the lipid POCT market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Lipid POCT Market Share Analysis
The lipid POCT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to lipid POCT market.
The major companies providing lipid POCT products in North America lipid POCT market are Abbott, F.Hoffmann-La Roche Ltd., and Nova Biomedical, Calligari Srl, AMD SOLUTIONS, EuroMedix, Siemens Healthcare GmbH (A Subsidiary of Siemens), Jant Pharmacal Corporation, Samsung Medison Co., Ltd., A. Menarini Diagnostics s.r.l, ACON Laboratories, Inc., PRIMA Lab SA, Quest Diagnostics Incorporated, and SKYLA CORPORATION among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the lipid POCT market.
For instance,
- In November 2020, SD Biosensor, INC. announced its partnership with DKSH Korea to develop pharmacy blood sugar business. This will help the company to diversify its market in coming years.
La collaboration, les coentreprises et d’autres stratégies des acteurs du marché améliorent le marché de l’entreprise sur le marché POCT lipidique, ce qui offre également l’avantage à l’organisation d’améliorer son offre pour le marché POCT lipidique.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA LIPID POCT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DISTRIBUTION CHANNEL LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 IMPROVING DIAGNOSIS SEEKING RATE
5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS
5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE
5.1.5 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 PRODUCT RECALLS
5.2.2 HIGH COSTS OF PRODUCTS
5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING HEALTHCARE EXPENDITURE
5.3.3 PANDEMIC OUTBREAK OF COVID-19
5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 LACK OF ACCESSIBILITY
6 IMPACT OF COVID-19 ON THE NORTH AMERICA LIPID POCT MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19
6.5 CONCLUSION:
1 NORTH AMERICA LIPID POCT MARKET, BY TYPE
1.1 OVERVIEW
1.2 INSTRUMENTS
1.2.1 ANALYZERS
1.2.1.1 PORTABLE
1.2.1.2 HANDHELD
1.2.1.3 STANDALONE
1.2.2 METER
1.2.3 BLOOD MONITORING DEVICE
1.2.4 OTHER POC PRODUCTS
1.3 CONSUMABLES AND KITS
1.3.1 CHOLESTEROL TEST KITS
1.3.2 STRIPS
1.3.3 ACCESSORIES
1.3.4 OTHERS
2 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION
2.1 OVERVIEW
2.2 HYPERLIPIDEMIA
2.3 HYPERTRIGLYCERIDEMIA
2.4 HYPERLIPOPROTEINEMIA
2.5 FAMILIAL HYPERCHOLESTEROLEMIA
2.6 TANGIER DISEASE
2.7 OTHERS
3 NORTH AMERICA LIPID POCT MARKET, BY MODE
3.1 OVERVIEW
3.2 PRESCRIPTION-BASED TESTING
3.3 OTC-BASED TESTING
4 NORTH AMERICA LIPID POCT MARKET, BY BRAND
4.1 OVERVIEW
4.2 ROCHE REFLOTRON
4.3 ROCHE COBAS B 101
4.4 ALERE CHOLESTECH LDX
4.5 ALERE AFINION
4.6 PTS CARDIOCHEK
4.7 OTHERS
5 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM
5.1 OVERVIEW
5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS
5.3 MOLECULAR DIAGNOSTICS
5.4 IMMUNOASSAYS
5.5 DIPSTICKS
5.6 MICROFLUIDICS
6 NORTH AMERICA LIPID POCT MARKET, BY END USER
6.1 OVERVIEW
6.2 HOSPITALS
6.3 PROFESSIONAL DIAGNOSTIC CENTERS
6.3.1 CLINICAL LABORATORIES
6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS
6.4 HOME CARE
6.5 RESEARCH LABORATORIES
6.6 OTHER END USERS
7 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 DIRECT TENDERS
7.3 RETAIL SALES
8 NORTH AMERICA LIPID POCT MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 U.S.
8.1.2 CANADA
8.1.3 MEXICO
9 NORTH AMERICA LIPID POCT MARKET: COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
10 SWOT ANALYSIS
11 COMPANY PROFILES
11.1 F. HOFFMANN-LA ROCHE LTD
11.1.1 COMPANY SNAPSHOT
11.1.2 REVENUE ANALYSIS
11.1.3 COMPANY SHARE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENT
11.2 ABBOTT
11.2.1 COMPANY SNAPSHOT
11.2.2 REVENUE ANALYSIS
11.2.3 COMPANY SHARE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENT
11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)
11.3.1 COMPANY SNAPSHOT
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 QUEST DIAGNOSTICS INCORPORATED
11.4.1 COMPANY SNAPSHOT
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPMENTS
11.5 A. MENARINI DIAGNOSTICS S.R.L
11.5.1 COMPANY SNAPSHOT
11.5.2 COMPANY SHARE ANALYSIS
11.5.3 PRODUCT PORTFOLIO
11.5.4 RECENT DEVELOPMENT
11.6 ACON LABORATORIES, INC.
11.6.1 COMPANY SNAPSHOT
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENT
11.7 AMD SOLUTIONS
11.7.1 COMPANY SNAPSHOT
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 CALLEGARI SRL
11.8.1 COMPANY SNAPSHOT
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 EUROMEDIX
11.9.1 COMPANY SNAPSHOT
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENT
11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.
11.10.1 COMPANY SNAPSHOT
11.10.2 PRODUCT PORTFOLIO
11.10.3 RECENT DEVELOPMENTS
11.11 JANT PHARMACAL CORPORATION
11.11.1 COMPANY SNAPSHOT
11.11.2 PRODUCT PORTFOLIO
11.11.3 RECENT DEVELOPMENT
11.12 MICO BIOMED
11.12.1 COMPANY SNAPSHOT
11.12.2 PRODUCT PORTFOLIO
11.12.3 RECENT DEVELOPMENTS
11.13 NOVA BIOMEDICAL
11.13.1 COMPANY SNAPSHOT
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 PRIMA LAB SA
11.14.1 COMPANY SNAPSHOT
11.14.2 PRODUCT PORTFOLIO
11.14.3 RECENT DEVELOPMENTS
11.15 PTS DIAGNOSTICS
11.15.1 COMPANY SNAPSHOT
11.15.2 PRODUCT PORTFOLIO
11.15.3 RECENT DEVELOPMENTS
11.16 SD BIOSENSOR, INC.
11.16.1 COMPANY SNAPSHOT
11.16.2 PRODUCT PORTFOLIO
11.16.3 RECENT DEVELOPMENTS
11.17 SKYLA CORPORATION
11.17.1 COMPANY SNAPSHOT
11.17.2 PRODUCT PORTFOLIO
11.17.3 RECENT DEVELOPMENTS
11.18 TASCOM
11.18.1 COMPANY SNAPSHOT
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENT
11.19 TRINITY BIOTECH
11.19.1 COMPANY SNAPSHOT
11.19.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.2 SAMSUNG MEDISON CO., LTD.
11.20.1 COMPANY SNAPSHOT
11.20.2 PRODUCT PORTFOLIO
11.20.3 RECENT DEVELOPMENT
12 QUESTIONNAIRE
13 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:
TABLE 1 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)
TABLE 15 NORTH AMERICA PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 50 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 U.S. LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 U.S. INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.S. ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 U.S. ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 58 U.S. CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 U.S. LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 U.S. LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 61 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 62 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 63 U.S. LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 64 U.S. LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 U.S. PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 U.S. LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 67 CANADA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 CANADA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 CANADA ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 70 CANADA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 71 CANADA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 CANADA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 CANADA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 74 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 75 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 76 CANADA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 77 CANADA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 CANADA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 CANADA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 MEXICO LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 MEXICO INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 MEXICO ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 83 MEXICO ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 84 MEXICO CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 MEXICO LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 MEXICO LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 87 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 88 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 89 MEXICO LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 90 MEXICO LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 91 MEXICO PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 MEXICO LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 NORTH AMERICA LIPID POCT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA LIPID POCT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA LIPID POCT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA LIPID POCT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA LIPID POCT MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA LIPID POCT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA LIPID POCT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA LIPID POCT MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE NORTH AMERICA LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA LIPID POCT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA LIPID POCT MARKET
FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT
FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016
FIGURE 1 NORTH AMERICA LIPID POCT MARKET: BY TYPE, 2020
FIGURE 2 NORTH AMERICA LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 3 NORTH AMERICA LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 4 NORTH AMERICA LIPID POCT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 5 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, 2020
FIGURE 6 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 7 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 8 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 9 NORTH AMERICA LIPID POCT MARKET: BY MODE, 2020
FIGURE 10 NORTH AMERICA LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)
FIGURE 11 NORTH AMERICA LIPID POCT MARKET: BY MODE, CAGR (2021-2028)
FIGURE 12 NORTH AMERICA LIPID POCT MARKET: BY MODE, LIFELINE CURVE
FIGURE 13 NORTH AMERICA LIPID POCT MARKET: BY BRAND, 2020
FIGURE 14 NORTH AMERICA LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)
FIGURE 15 NORTH AMERICA LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)
FIGURE 16 NORTH AMERICA LIPID POCT MARKET: BY BRAND, LIFELINE CURVE
FIGURE 17 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, 2020
FIGURE 18 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)
FIGURE 20 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 21 NORTH AMERICA LIPID POCT MARKET: BY END USER, 2020
FIGURE 22 NORTH AMERICA LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA LIPID POCT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 24 NORTH AMERICA LIPID POCT MARKET: BY END USER, LIFELINE CURVE
FIGURE 25 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 26 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 28 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 29 NORTH AMERICA LIPID POCT MARKET: SNAPSHOT (2020)
FIGURE 30 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2020)
FIGURE 31 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 32 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 33 NORTH AMERICA LIPID POCT MARKET: BY TYPE (2021-2028)
FIGURE 34 NORTH AMERICA LIPID POCT MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
